Considerations for treatment of lipid disorders during pregnancy and breastfeeding

Prog Cardiovasc Dis. 2022 Nov-Dec:75:33-39. doi: 10.1016/j.pcad.2022.11.001. Epub 2022 Nov 16.

Abstract

Adequate management of lipid disorders during pregnancy is essential given the association of dyslipidemia with adverse pregnancy outcomes. While there are physiologic changes in lipid levels that occur with normal pregnancy, abnormal alterations in lipids can lead to increased future risk of atherosclerotic cardiovascular disease. There are inherent challenges in the treatment of dyslipidemias during pregnancy and the postpartum period given the lack of adequate data in this population and the contraindication of traditional therapeutic agents. However, it remains of utmost importance to optimize screening and identification of patients at high-risk for atherosclerotic cardiovascular disease so that proper counseling can be provided and the risk for pregnancy complications and downstream cardiovascular complications can be addressed. In this review, we summarize the literature on the association of dyslipidemia in pregnancy with adverse outcomes and discuss considerations for the management of lipid disorders during both pregnancy and breastfeeding.

Keywords: Atherosclerotic cardiovascular disease; Breast feeding; Dyslipidemia; Hypercholesterolemia; Lipids; Pregnancy.

Publication types

  • Review

MeSH terms

  • Atherosclerosis*
  • Cardiovascular Diseases* / prevention & control
  • Dyslipidemias* / diagnosis
  • Dyslipidemias* / drug therapy
  • Female
  • Humans
  • Lipids
  • Pregnancy

Substances

  • Lipids